Bullfrog AI Holdings, Inc. (BFRG)

NCM – Real Time Price. Currency in USD

0.65

+0.04 (7.18%)

At close: Jun 26, 2026, 4:00 PM EDT

0.64

-0.02 (-3.04%)

After-hours: Jun 26, 2026, 7:44 PM EDT

02.06.2026

BullFrog AI Announces New Commercial Leadership Team to Execute Growth Strategy for its Integrated Pharma AI Platform

GAITHERSBURG, Md., June 02, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology company using artificial intelligence (“AI”) and machine learning to turn complex biomedical data into actionable insights, today announced it has appointed commercial technology sales and scientific-focused leaders to support the momentum of the Company's commercial business driven growth strategy.

22.04.2026

BullFrog AI Regains Compliance with Nasdaq Shareholders' Equity Requirement

GAITHERSBURG, Md., April 22, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology company using artificial intelligence (“AI”) and machine learning to turn complex biomedical data into actionable insights, today announced that it has received a written notice from The Nasdaq Stock Market LLC ("Nasdaq") stating that the Company has regained compliance with the minimum stockholders' equity requirement under Nasdaq Listing Rule 5550(b)(1) (the “Stockholders' Equity Rule”).

14.04.2026

BullFrog AI Announces Participation at AACR Annual Meeting

BullFrog AI team will be available to discuss its end-to-end drug discovery and development workflow at booth 2957 BullFrog AI team will be available to discuss its end-to-end drug discovery and development workflow at booth 2957

13.04.2026

BullFrog AI Provides Business Update: Strengthened Balance Sheet Supports Continued Execution as Company Aims to Ramp Commercial Activity with Global Pharmaceutical and Biotechnology Partners

GAITHERSBURG, Md., April 13, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (Nasdaq: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology company using artificial intelligence and machine learning to turn complex biomedical data into actionable insights, today issued the following letter to shareholders from Vin Singh, Founder and CEO: Dear Fellow Shareholders, BullFrog AI enters the second quarter of 2026 well-capitalized, at commercial stage, and in active discussions with consequential pharmaceutical and biotechnology organizations.

31.03.2026

BullFrog AI Shares Surge On Deal With Top Pharma Company For MDD Drug Targets

BullFrog said the agreement will utilize its end-to-end analytical AI platform to accelerate the partner's drug discovery and clinical development program for MDD.

30.03.2026

Bullfrog AI stock offers a rare opportunity for investors to take profit

Bullfrog AI Inc more than doubled on Mar. 30 after announcing a landmark commercial agreement with a “top 5” pharma leader to identify novel therapeutic targets for Major Depressive Disorder. In its press release, BFRG said the pharmaceutical giant has agreed to use its proprietary bfLEAP® platform – providing high-profile validation of its machine-leaning-driven drug discovery tech.

30.03.2026

Dow Gains 200 Points; Bullfrog AI Shares Jump

U.S. stocks traded mostly higher this morning, with the Dow Jones index gaining around 200 points on Monday.

Bullfrog AI Holdings, Inc. (BFRG)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Bullfrog AI Holdings, Inc. (BFRG)

BullFrog AI Announces New Commercial Leadership Team to Execute Growth Strategy for its Integrated Pharma AI Platform

BullFrog AI Regains Compliance with Nasdaq Shareholders' Equity Requirement

BullFrog AI Announces Participation at AACR Annual Meeting

BullFrog AI Provides Business Update: Strengthened Balance Sheet Supports Continued Execution as Company Aims to Ramp Commercial Activity with Global Pharmaceutical and Biotechnology Partners

BullFrog AI Shares Surge On Deal With Top Pharma Company For MDD Drug Targets

Bullfrog AI stock offers a rare opportunity for investors to take profit

Dow Gains 200 Points; Bullfrog AI Shares Jump

BullFrog AI Announces New Commercial Leadership Team to Execute Growth Strategy for its Integrated Pharma AI Platform

BullFrog AI Regains Compliance with Nasdaq Shareholders' Equity Requirement

BullFrog AI Announces Participation at AACR Annual Meeting

BullFrog AI Provides Business Update: Strengthened Balance Sheet Supports Continued Execution as Company Aims to Ramp Commercial Activity with Global Pharmaceutical and Biotechnology Partners

BullFrog AI Shares Surge On Deal With Top Pharma Company For MDD Drug Targets

Bullfrog AI stock offers a rare opportunity for investors to take profit

Dow Gains 200 Points; Bullfrog AI Shares Jump

Videos

No Data

Press releases

BullFrog AI Announces New Commercial Leadership Team to Execute Growth Strategy for its Integrated Pharma AI Platform

BullFrog AI Regains Compliance with Nasdaq Shareholders' Equity Requirement

BullFrog AI Announces Participation at AACR Annual Meeting

BullFrog AI Provides Business Update: Strengthened Balance Sheet Supports Continued Execution as Company Aims to Ramp Commercial Activity with Global Pharmaceutical and Biotechnology Partners

Search stocks

Bullfrog AI Holdings, Inc. (BFRG)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Bullfrog AI Holdings, Inc. (BFRG)

BullFrog AI Announces New Commercial Leadership Team to Execute Growth Strategy for its Integrated Pharma AI Platform

BullFrog AI Regains Compliance with Nasdaq Shareholders' Equity Requirement

BullFrog AI Announces Participation at AACR Annual Meeting

BullFrog AI Provides Business Update: Strengthened Balance Sheet Supports Continued Execution as Company Aims to Ramp Commercial Activity with Global Pharmaceutical and Biotechnology Partners

BullFrog AI Shares Surge On Deal With Top Pharma Company For MDD Drug Targets

Bullfrog AI stock offers a rare opportunity for investors to take profit

Dow Gains 200 Points; Bullfrog AI Shares Jump

BullFrog AI Announces New Commercial Leadership Team to Execute Growth Strategy for its Integrated Pharma AI Platform

BullFrog AI Regains Compliance with Nasdaq Shareholders' Equity Requirement

BullFrog AI Announces Participation at AACR Annual Meeting

BullFrog AI Provides Business Update: Strengthened Balance Sheet Supports Continued Execution as Company Aims to Ramp Commercial Activity with Global Pharmaceutical and Biotechnology Partners

BullFrog AI Shares Surge On Deal With Top Pharma Company For MDD Drug Targets

Bullfrog AI stock offers a rare opportunity for investors to take profit

Dow Gains 200 Points; Bullfrog AI Shares Jump

Videos

No Data

Press releases

BullFrog AI Announces New Commercial Leadership Team to Execute Growth Strategy for its Integrated Pharma AI Platform

BullFrog AI Regains Compliance with Nasdaq Shareholders' Equity Requirement

BullFrog AI Announces Participation at AACR Annual Meeting

BullFrog AI Provides Business Update: Strengthened Balance Sheet Supports Continued Execution as Company Aims to Ramp Commercial Activity with Global Pharmaceutical and Biotechnology Partners